Clinical features, treatment, and prognosis of nivolumab induced immune encephalitis.
- Published in:
- Investigational New Drugs, 2025, v. 43, n. 2, p. 293, doi. 10.1007/s10637-025-01522-x
- By:
- Publication type:
- Article
Works by Wu, Zhaoquan
Results: 14
1
2
Retrospective analysis of clinical features of nivolumab-induced immune-related pancreatitis.
- Published in:
- Investigational New Drugs, 2025, v. 43, n. 2, p. 276, doi. 10.1007/s10637-025-01517-8
- By:
- Publication type:
- Article
3
Clinical characteristics, treatment, and outcomes of nivolumab-induced uveitis.
- Published in:
- Immunopharmacology & Immunotoxicology, 2025, v. 47, n. 2, p. 222, doi. 10.1080/08923973.2025.2461056
- By:
- Publication type:
- Article
4
Identification of anti-nociceptive constituents from the pollen of Typha angustifolia L. using effect-directed fractionation.
- Published in:
- Natural Product Research, 2020, v. 34, n. 7, p. 1041, doi. 10.1080/14786419.2018.1539979
- By:
- Publication type:
- Article
5
Polyphenolic glycosides isolated from Pogostemon cablin (Blanco) Benth. as novel influenza neuraminidase inhibitors.
- Published in:
- Chemistry Central Journal, 2016, v. 10, p. 1, doi. 10.1186/s13065-016-0192-x
- By:
- Publication type:
- Article
6
Clinical features, treatment, and prognosis of pembrolizumab -induced Stevens-Johnson syndrome / toxic epidermal necrolysis.
- Published in:
- Investigational New Drugs, 2025, v. 43, n. 1, p. 74, doi. 10.1007/s10637-024-01499-z
- By:
- Publication type:
- Article
7
Clinical characteristics, treatment, and outcomes of nivolumab induced immune thrombocytopenia.
- Published in:
- Investigational New Drugs, 2024, v. 42, n. 5, p. 575, doi. 10.1007/s10637-024-01472-w
- By:
- Publication type:
- Article
8
Clinical characteristics, treatment, and outcomes of pembrolizumab-induced uveitis.
- Published in:
- Investigational New Drugs, 2024, v. 42, n. 5, p. 510, doi. 10.1007/s10637-024-01464-w
- By:
- Publication type:
- Article
9
Identification of the Hypoglycemic Active Components of Lonicera japonica Thunb. and Lonicera hypoglauca Miq. by UPLC-Q-TOF-MS.
- Published in:
- Molecules, 2024, v. 29, n. 20, p. 4848, doi. 10.3390/molecules29204848
- By:
- Publication type:
- Article
10
Clinical characteristics, treatment and outcome of subacute cutaneous lupus erythematosus induced by PD-1/PD-L1 inhibitors.
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 10, p. 1, doi. 10.1007/s00403-024-03484-1
- By:
- Publication type:
- Article
11
Clinical characteristics, treatment and outcome of subacute cutaneous lupus erythematosus induced by PD-1/PD-L1 inhibitors.
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 10, p. 1, doi. 10.1007/s00403-024-03484-1
- By:
- Publication type:
- Article
12
Clinical features, treatment, and outcome of granulocyte colony stimulating factor-induced sweet syndrome.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
13
Clinical characteristics, treatment and outcome of clindamycin induced acute generalized exanthematous pustulosis.
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 8, p. 1, doi. 10.1007/s00403-024-03310-8
- By:
- Publication type:
- Article
14
Drug metabolism and transport mediated the hepatotoxicity of Pleuropterus multiflorus root: a review.
- Published in:
- Drug Metabolism Reviews, 2024, v. 56, n. 4, p. 349, doi. 10.1080/03602532.2024.2405163
- By:
- Publication type:
- Article